市場調査レポート

商品コード

薬物動態サービスの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート：薬剤タイプ別、サービスタイプ別、治療用途別、エンドユーザー別、地域別

Pharmacokinetics Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Type, Service Type, Therapeutic Application, and End User, and Geography

出版日: 2024年05月23日
発行: The Insight Partners
ページ情報: 英文 174 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 641,067円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 929,187円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,217,307円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

薬物動態サービスの市場規模は、2023年の8億7,496万米ドルから2031年には15億7,987万米ドルに達すると予測されています。2023～2031年のCAGRは7.6%と予測されます。

薬物動態サービス市場の市場促進要因

慢性疾患と感染症の有病率の上昇

糖尿病、がん、自己免疫疾患などの慢性疾患の有病率の増加は、世界中で医薬品開発への取り組みを促進する要因となっています。世界保健機関（WHO）の2024年のデータによると、世界で4億2,200万人が糖尿病に罹患しており、これらの症例は主に中低所得国に見られ、毎年約150万人が死亡しています。製薬会社は、様々な病気の治療薬を開発する最前線にいます。薬物動態学的研究は、人体内での吸収、分布、代謝、排泄（ADME）の過程を分析することにより、これらの薬剤が患者の体内でどのように作用するかを理解するために不可欠です。薬物の全身循環への吸収は、薬物が作用部位（例えば血漿）に到達する速度と濃度に影響します。全身における薬物の分布パターンは、その生化学的特性と身体生理学に基づいて変化します。代謝は、薬物が体内で処理され、後続の化合物に変化することを含みます。この段階は、薬物を水溶性物質に変換し、腎クリアランスに適した状態にするために重要です。代謝はまた、コデインなどのプロドラッグを活性代謝物に変換するためにも重要です。体内からの薬物の排泄は主に腎臓によって行われるが、肺、皮膚、消化管から排泄される場合もあります。ADME動態は体内での薬物のバイオアベイラビリティを規定し、薬物の維持用量はそのクリアランス時間（所望の血漿中濃度÷バイオアベイラビリティ）に基づいて計算されます。クリアランスを理解することで、当業者は適切な投与速度を計算することができます。

薬物動態試験は、薬剤の有効性と安全性を理解するために、被験者の薬物投与レジメンを最適化することに焦点を当てています。これらの試験は、長期治療用に開発された薬剤の安全性を確保するために不可欠であり、慢性疾患管理における薬剤製剤の適合性と安定性を評価するのに役立ちます。それゆえ、慢性疾患や感染症の負担増は、安全で効果的な個別化治療を開発するための薬物動態試験の重要性を強調しています。

薬物動態サービス市場における機会

医薬品製造時に発生する膨大な薬物動態データの収集と取り扱いは、高価で面倒で時間のかかる作業です。こうした作業には労力とコストがかかるため、薬物動態パラメータを予測するための薬物動態シミュレーションモデルやin vitro-in vivo薬物動態相関モデル（IVIVC）などのモデルの必要性が浮き彫りになっています。薬物動態シミュレーションモデルは、計算および数学的モデルを用いて、特定の条件下における生活環境での薬物動態を解釈するツールです。また、IVIVCモデルは創薬プロセスの基本的な部分です。医薬品開発の初期段階でPK/PD予測を分析することは、リード化合物の最適化戦略に必要であり、また、減少率をさらに低減するためにも必要です。薬物動態特性を改善し、特徴付けるための新しいin-vitroおよびin-vivo戦略の開発において、著しい進歩が見られます。IVIVCモデルは、薬剤のバイオアベイラビリティやその応用を分析する生物薬剤学的特性を評価するための費用対効果の高い選択肢として提案されています。したがって、このようなin-vivoおよびin-vitroモデルは、近い将来、薬物動態サービス市場に有利な機会を提供すると予想されます。

薬物動態サービス市場セグメント別概要

薬物タイプ別では、市場は低分子、高分子、ワクチンに区分されます。2023年には低分子セグメントが最大の市場シェアを占めています。

薬物動態サービス市場は、治療用途別に、がん、感染症、神経疾患、自己免疫疾患、婦人科疾患、心血管疾患、呼吸器疾患、その他に分類されます。2023年には、がん領域が最大の市場シェアを占めています。

薬物動態サービス市場地理的概観

北米が最大シェアを占めています。カナダ政府の報告書によると、カナダ保健省は、新薬（ワクチンを含む）の試験や、承認された医薬品の新たな用途を導入するために、何百件もの新規臨床試験申請を受けています。カナダ国内の小児患者（小児および青少年）は、両親の許可を得て臨床試験に参加します。カナダ保健省は、小児や青少年を含む臨床試験に参加する個人を保護しています。カナダ臨床試験資産マップ（CCTAM）報告書によると、カナダでは2022年に～3,500件の臨床試験が登録され、中でもがん治療薬は重要な重点分野であり、2021年には1,300件のがん臨床試験が登録されました。Innovative Medicines Canadaの報告書によると、製薬業界はカナダの臨床研究に12億米ドルを投資しました。さらに、カナダ臨床試験ネットワーク（CCTN）では、2021年時点で600万人以上の患者記録が管理されています。このように、薬物動態サービスに対する需要は、カナダにおける医薬品開発と発見プロジェクトの急増に伴って増加します。このように、臨床試験や調査研究の増加、感染症や慢性疾患の有病率の増加は、カナダにおける薬物動態サービス市場の成長を促進する要因の一つです。

薬物動態サービス市場- 主な市場力学
市場促進要因
- 慢性疾患および感染症の有病率の上昇
- 薬物動態試験の適用範囲の拡大
- CROへの薬物動態サービスのアウトソーシング
市場抑制要因
- 新興国における薬物動態サービスプロバイダーの限定的なリーチ
市場機会
- 薬物動態のばらつきを理解するための生体内および生体外モデルの採用の増加
今後の動向
- 薬物動態サービスにおけるビッグデータ解析の採用増加
促進要因と阻害要因の影響

第6章薬物動態サービス市場-世界市場分析

薬物動態サービス市場の収益、2023-2031年

第7章薬物動態サービス市場分析：薬物タイプ別

低分子
大分子
ワクチン

第8章薬物動態サービス市場分析：サービスタイプ別

前臨床ADMEおよびヒト試験
PK/PD分析とレポーティング
投与シミュレーション
リスク分析
その他

第9章薬物動態サービス市場分析：治療用途別

がん領域
感染症
神経疾患
自己免疫疾患
婦人科疾患
循環器疾患
呼吸器疾患
その他

第10章薬物動態サービス市場分析：エンドユーザー別

製薬企業およびバイオテクノロジー企業
受託研究機関
その他

第11章薬物動態サービス市場：地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- APACその他
中東・アフリカ
- サウジアラビア
- 南アフリカ
- アラブ首長国連邦
- その他中東とアフリカ
中南米
- ブラジル
- アルゼンチン
- その他中南米

第12章企業プロファイル

Charles River Laboratories International Inc
Eurofins Scientific SE
Evotec SE
Certara Inc.
Parexel International Corp
Thermo Fisher Scientific Inc.
Allucent
PACIFIC BIOLABS
SGS SA
Shanghai Medicilon Inc.

第13章付録

図表

List Of Tables

Table 1. Pharmacokinetics Services Market Segmentation
Table 2. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 3. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 4. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 5. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 6. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 7. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 8. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 9. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 10. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 11. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 12. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 13. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 14. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 15. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 16. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 17. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 19. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 20. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 21. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 22. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 23. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 24. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 25. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 27. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 28. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 29. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 30. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 31. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 32. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 33. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 34. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 35. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 36. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 37. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 38. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 39. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 40. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 41. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 42. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 43. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 44. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 45. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 46. R&D Expenditure of Indian Companies, 2018-2020 (US$ Million)
Table 47. Company
Table 48. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 49. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 50. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 51. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 52. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 53. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 54. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 55. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 56. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 57. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 58. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 59. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 60. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 61. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 62. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 63. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 64. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 65. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 66. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 67. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 68. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 69. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 70. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 71. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 72. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 73. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 74. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 75. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 76. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 77. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 78. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 79. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 80. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 81. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 82. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 83. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 84. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 85. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 86. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 87. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 88. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 89. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 90. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 91. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User

List Of Figures

Figure 1. Pharmacokinetics Services Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Pharmacokinetics Services Market Revenue (US$ Million), 2023-2031
Figure 5. Pharmacokinetics Services Market, By Geography Forecast Analysis, 2023 & 2031
Figure 6. Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 7. Small Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Large Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Vaccines: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 11. Pre-Clinical ADME and Human Studies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. PK/PD Analysis and Reporting: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Dosing Simulations: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Risk Analysis: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 17. Oncology: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Infectious Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Neurological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Autoimmune Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Gynecological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Cardiovascular Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Respiratory Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)
Figure 26. Pharmaceutical and Biotechnology Companies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Contract Research Organization: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. North America: Pharmacokinetics Services Market by Key Countries - Revenue (2023) US$ Million
Figure 30. North America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. North America: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 32. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Europe: Pharmacokinetics Services Market - Revenue by Key Countries Revenue 2023 (US$ Million)
Figure 36. Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 37. Europe: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 38. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Asia Pacific: Pharmacokinetics Services Market - Revenue by Key Countries 2023 (US$ Million)
Figure 45. Asia Pacific: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 47. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 48. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 49. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 50. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 51. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Middle East and Africa: Pharmacokinetics Services Market by Key Countries - Revenue 2023 (US$ Million)
Figure 54. Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 55. Pharmacokinetics Services Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 56. Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 57. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 58. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 59. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 60. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 61. South and Central America: Pharmacokinetics Services Market by Key Countries - Revenue 2023 (US$ Million)
Figure 62. South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 63. Pharmacokinetics Services Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 64. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 65. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 66. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)

Product Code: TIPRE00007438

The pharmacokinetics services market size is projected to reach US$ 1,579.87 million by 2031 from US$ 874.96 million in 2023. The market is expected to register a CAGR of 7.6% during 2023-2031.

Market Drivers of the Pharmacokinetics Services Market

Rising Prevalence of Chronic and Infectious Diseases

The growing prevalence of chronic diseases such as diabetes, cancer, and autoimmune diseases has been a prime enabler of drug development efforts across the world. According to the World Health Organization's (WHO) 2024 data, ~422 million in the world suffer from diabetes, and these cases are mostly found in middle and low-income countries, causing approximately 1.5 million deaths every year. Pharmaceutical companies are at the forefront of developing drugs to treat various diseases. Pharmacokinetic studies are essential for understanding how these drugs behave in a patient's body by analyzing the process of absorption, distribution, metabolization, and elimination (ADME) within the human body. The absorption of a drug into systemic circulation affects the speed and concentration at which a drug may reach the site of action, e.g., plasma. Drug distribution pattern throughout the body varies based on its biochemical properties and body physiology. Metabolism involves the processing of the drug by the body into subsequent compounds. This step is instrumental in converting the drug into water-soluble substances to render them suitable for renal clearance. Metabolism is also important for the conversion of prodrugs, such as codeine, into active metabolites. Excretion of drugs from the body is mainly governed by kidneys; however, in several cases, drugs may be excreted via the lungs, skin, or gastrointestinal tract. ADME dynamics define the bioavailability of drugs in the body, and the maintenance doses of drugs are calculated based on their clearance times (desired plasma concentration divided by bioavailability). Understanding of clearance allows practitioners to calculate appropriate dosing rates.

Pharmacokinetic studies focus on optimizing drug dose regimens in study subjects to understand the efficacy and safety of a drug. These studies are essential for ensuring the safety of drugs that are developed for long-term treatments, which helps evaluate the suitability and stability of drug formulations in chronic disease management. Hence, the rising burden of chronic and infectious diseases underlines the importance of pharmacokinetic studies to develop safe and effective personalized treatments.

Opportunities in the Pharmacokinetics Services Market

The collection and handling of huge pharmacokinetic data generated during drug manufacturing are expensive, tedious, and time-consuming tasks. The labor- and cost-intensive nature of these tasks highlights the need for models such as pharmacokinetic simulation models and in vitro-in vivo pharmacokinetic correlation models (IVIVC) for the prediction of pharmacokinetic parameters. The pharmacokinetic simulation model is a tool that interprets drug kinetics in the living environment under specific conditions using computational and mathematical models. In addition, the IVIVC model are a fundamental part of the drug discovery process. Analyzing PK/PD predictions at the early stages of drug development is necessary for lead optimization strategies and also to further reduce attrition rates. There have been significant advancements in the development of new in-vitro and in-vivo strategies to improve and characterize pharmacokinetic properties. IVIVC models are being proposed as a cost-effective alternative to assess the biopharmaceutical properties that analyze the bioavailability of drugs and their application. Hence, such in-vivo and in-vitro models are anticipated to provide lucrative opportunities for the pharmacokinetics services market in the near future.

Pharmacokinetics Services Market: Segmental Overview

By drug type, the market is segmented into small molecules, large molecules, and vaccines. The small molecule segment held the largest market share in 2023.

The pharmacokinetics services market, by therapeutic application, is categorized into oncology, infectious diseases, neurological disorders, autoimmune diseases, gynecological disorders, cardiovascular diseases, respiratory disorders, and others. The oncology segment held the largest market share in 2023.

Pharmacokinetics Services Market: Geographical Overview

North America held the largest share of the market. According to a report by the Government of Canada, Health Canada receives hundreds of new clinical trial applications to test new drugs (including vaccines) or to introduce new uses of approved medicines. Pediatric patients (children and youth) in the country participate in clinical trials with their parents' permission. Health Canada protects individuals participating in clinical trials, including children and youth. According to the Canadian Clinical Trials Asset Map (CCTAM) report, ~3,500 clinical trials were registered in Canada in 2022, with cancer therapeutics being a significant area of focus, accounting for 1,300 cancer clinical trials in 2021. The pharmaceutical industry invested ~US$ 1.2 billion in clinical research in Canada, per the Innovative Medicines Canada report. Further, the Canadian Clinical Trials Network (CCTN) had over 6 million patient records maintained as of 2021. Thus, the demand for pharmacokinetic services increases with the surge in drug development and discovery projects in Canada. Thus, the rising number of clinical trials and research studies, and the increasing prevalence of infectious diseases and chronic disorders are among the factors propelling the pharmacokinetics services market growth in Canada.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Pharmacokinetics Services Market Landscape

4.1 PEST Analysis

5. Pharmacokinetics Services Market - Key Market Dynamics

5.1 Pharmacokinetics Services Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Chronic and Infectious Diseases
- 5.2.2 Expanding Range of Application of Pharmacokinetic Studies
- 5.2.3 Outsourcing of Pharmacokinetics Services to CROs
5.3 Market Restraints
- 5.3.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
5.4 Market Opportunities
- 5.4.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
5.5 Future Trend
- 5.5.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
5.6 Impact of Drivers and Restraints:

6. Pharmacokinetics Services Market - Global Market Analysis

6.1 Pharmacokinetics Services Market Revenue (US$ Million), 2023-2031

7. Pharmacokinetics Services Market Analysis - by Drug Type

7.1 Overview
7.2 Small Molecule
- 7.2.1 Overview
- 7.2.2 Small Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Large Molecule
- 7.3.1 Overview
- 7.3.2 Large Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Vaccines
- 7.4.1 Overview
- 7.4.2 Vaccines: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8. Pharmacokinetics Services Market Analysis - by Service Type

8.1 Pre-Clinical ADME and Human Studies
- 8.1.1 Overview
- 8.1.2 Pre-Clinical ADME and Human Studies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 PK/PD Analysis and Reporting
- 8.2.1 Overview
- 8.2.2 PK/PD Analysis and Reporting: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Dosing Simulations
- 8.3.1 Overview
- 8.3.2 Dosing Simulations: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Risk Analysis
- 8.4.1 Overview
- 8.4.2 Risk Analysis: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9. Pharmacokinetics Services Market Analysis - by Therapeutic Application

9.1 Oncology
- 9.1.1 Overview
- 9.1.2 Oncology: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Infectious Diseases
- 9.2.1 Overview
- 9.2.2 Infectious Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Neurological Disorders
- 9.3.1 Overview
- 9.3.2 Neurological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Autoimmune Diseases
- 9.4.1 Overview
- 9.4.2 Autoimmune Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Gynecological Disorders
- 9.5.1 Overview
- 9.5.2 Gynecological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Cardiovascular Diseases
- 9.6.1 Overview
- 9.6.2 Cardiovascular Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Respiratory Disorders
- 9.7.1 Overview
- 9.7.2 Respiratory Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10. Pharmacokinetics Services Market Analysis - by End User

10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Pharmaceutical and Biotechnology Companies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Contract Research Organization
- 10.2.1 Overview
- 10.2.2 Contract Research Organization: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
- 10.3.1 Overview
- 10.3.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11. Pharmacokinetics Services Market - Geographical Analysis

11.1 North America
- 11.1.1 North America Pharmacokinetics Services Market Overview
- 11.1.2 North America: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
  - 11.1.2.1 United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.2.1.1 Overview
    - 11.1.2.1.2 United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.2.1.3 United States: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.1.2.1.4 United States: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.1.2.1.5 United States: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.1.2.1.6 United States: Pharmacokinetics Services Market Breakdown, by End User
  - 11.1.2.2 Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.2.2.1 Overview
    - 11.1.2.2.2 Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.2.2.3 Canada: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.1.2.2.4 Canada: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.1.2.2.5 Canada: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.1.2.2.6 Canada: Pharmacokinetics Services Market Breakdown, by End User
  - 11.1.2.3 Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.2.3.3 Mexico: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.1.2.3.4 Mexico: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.1.2.3.5 Mexico: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.1.2.3.6 Mexico: Pharmacokinetics Services Market Breakdown, by End User
11.2 Europe
- 11.2.1 Europe Pharmacokinetics Services Market Overview
- 11.2.2 Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.3 Pharmacokinetics Services Market Breakdown by Countries
- 11.2.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
  - 11.2.4.1 Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.4.1.1 Overview
    - 11.2.4.1.2 Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.4.1.3 Germany: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.2.4.1.4 Germany: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.2.4.1.5 Germany: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.2.4.1.6 Germany: Pharmacokinetics Services Market Breakdown, by End User
  - 11.2.4.2 France: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.4.2.1 Overview
    - 11.2.4.2.2 France: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.4.2.3 France: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.2.4.2.4 France: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.2.4.2.5 France: Pharmacokinetics Services Market Breakdown, by Therapeutic Application

The market for infectious diseases segment is estimated to be worth US$ 19.24 million by 2031 and is expected to register a CAGR of 10.8% during the 2023-2031.

11.2.4.2.6 France: Pharmacokinetics Services Market Breakdown, by End User

11.2.4.3 United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.3.1 Overview
- 11.2.4.3.2 United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.3.3 United Kingdom: Pharmacokinetics Services Market Breakdown, by Drug Type
- 11.2.4.3.4 United Kingdom: Pharmacokinetics Services Market Breakdown, by Service Type
- 11.2.4.3.5 United Kingdom: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
- 11.2.4.3.6 United Kingdom: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.4 Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.4.1 Overview
- 11.2.4.4.2 Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.4.3 Italy: Pharmacokinetics Services Market Breakdown, by Drug Type
- 11.2.4.4.4 Italy: Pharmacokinetics Services Market Breakdown, by Service Type
- 11.2.4.4.5 Italy: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
- 11.2.4.4.6 Italy: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.5 Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.5.1 Overview
- 11.2.4.5.2 Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.5.3 Spain: Pharmacokinetics Services Market Breakdown, by Drug Type
- 11.2.4.5.4 Spain: Pharmacokinetics Services Market Breakdown, by Service Type
- 11.2.4.5.5 Spain: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
- 11.2.4.5.6 Spain: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.6 Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.6.1 Overview
- 11.2.4.6.2 Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2.4.6.3 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Drug Type
- 11.2.4.6.4 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Service Type
- 11.2.4.6.5 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
- 11.2.4.6.6 Rest of Europe: Pharmacokinetics Services Market Breakdown, by End User

11.3 Asia Pacific
- 11.3.1 Asia Pacific Pharmacokinetics Services Market Overview
- 11.3.2 Asia Pacific: Pharmacokinetics Services Market
- 11.3.3 Asia Pacific: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
  - 11.3.3.1 China: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.1.1 Overview
    - 11.3.3.1.2 China: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.1.3 China: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.3.3.1.4 China: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.3.3.1.5 China: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.3.3.1.6 China: Pharmacokinetics Services Market Breakdown, by End User
  - 11.3.3.2 Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.2.1 Overview
    - 11.3.3.2.2 Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.2.3 Japan: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.3.3.2.4 Japan: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.3.3.2.5 Japan: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.3.3.2.6 Japan: Pharmacokinetics Services Market Breakdown, by End User
  - 11.3.3.3 India: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.3.1 Overview
    - 11.3.3.3.2 India: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.3.3 India: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.3.3.3.4 India: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.3.3.3.5 India: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.3.3.3.6 India: Pharmacokinetics Services Market Breakdown, by End User
  - 11.3.3.4 Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.4.1 Overview
    - 11.3.3.4.2 Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.4.3 Australia: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.3.3.4.4 Australia: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.3.3.4.5 Australia: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.3.3.4.6 Australia: Pharmacokinetics Services Market Breakdown, by End User
  - 11.3.3.5 South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.5.1 Overview
    - 11.3.3.5.2 South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.5.3 South Korea: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.3.3.5.4 South Korea: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.3.3.5.5 South Korea: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.3.3.5.6 South Korea: Pharmacokinetics Services Market Breakdown, by End User
  - 11.3.3.6 Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.6.1 Overview
    - 11.3.3.6.2 Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.6.3 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.3.3.6.4 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.3.3.6.5 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.3.3.6.6 Rest of APAC: Pharmacokinetics Services Market Breakdown, by End User
11.4 Middle East and Africa
- 11.4.1 Middle East and Africa Pharmacokinetics Services Market Overview
- 11.4.2 Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.4.3 Pharmacokinetics Services Market Breakdown by Countries
- 11.4.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
- 11.4.5 Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
  - 11.4.5.1 Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.1.1 Overview
    - 11.4.5.1.2 Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.1.3 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.4.5.1.4 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.4.5.1.5 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.4.5.1.6 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by End User
  - 11.4.5.2 South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.2.1 Overview
    - 11.4.5.2.2 South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.2.3 South Africa: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.4.5.2.4 South Africa: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.4.5.2.5 South Africa: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.4.5.2.6 South Africa: Pharmacokinetics Services Market Breakdown, by End User
  - 11.4.5.3 United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.3.1 Overview
    - 11.4.5.3.2 United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.3.3 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.4.5.3.4 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.4.5.3.5 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.4.5.3.6 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by End User
  - 11.4.5.4 Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.4.1 Overview
    - 11.4.5.4.2 Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.5.4.3 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.4.5.4.4 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.4.5.4.5 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.4.5.4.6 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by End User
11.5 South and Central America
- 11.5.1 South and Central America Pharmacokinetics Services Market Overview
- 11.5.2 South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- 11.5.3 Pharmacokinetics Services Market Breakdown by Countries
- 11.5.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
  - 11.5.4.1 Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.4.1.1 Overview
    - 11.5.4.1.2 Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.4.1.3 Brazil: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.5.4.1.4 Brazil: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.5.4.1.5 Brazil: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.5.4.1.6 Brazil: Pharmacokinetics Services Market Breakdown, by End User
  - 11.5.4.2 Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.4.2.1 Overview
    - 11.5.4.2.2 Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.4.2.3 Argentina: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.5.4.2.4 Argentina: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.5.4.2.5 Argentina: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.5.4.2.6 Argentina: Pharmacokinetics Services Market Breakdown, by End User
  - 11.5.4.3 Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.4.3.1 Overview
    - 11.5.4.3.2 Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.4.3.3 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Drug Type
    - 11.5.4.3.4 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Service Type
    - 11.5.4.3.5 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
    - 11.5.4.3.6 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by End User

12. Company Profile

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Eurofins Scientific SE
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Evotec SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Certara Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
12.5 Parexel International Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Allucent
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PACIFIC BIOLABS
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 SGS SA
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Shanghai Medicilon Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

薬物動態サービスの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート：薬剤タイプ別、サービスタイプ別、治療用途別、エンドユーザー別、地域別

Pharmacokinetics Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Type, Service Type, Therapeutic Application, and End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章薬物動態サービス市場情勢

第5章薬物動態サービス市場：主要市場力学

第6章薬物動態サービス市場-世界市場分析

第7章薬物動態サービス市場分析：薬物タイプ別

第8章薬物動態サービス市場分析：サービスタイプ別

第9章薬物動態サービス市場分析：治療用途別

第10章薬物動態サービス市場分析：エンドユーザー別

第11章薬物動態サービス市場：地域別分析

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Pharmacokinetics Services Market Landscape

5. Pharmacokinetics Services Market - Key Market Dynamics

6. Pharmacokinetics Services Market - Global Market Analysis

7. Pharmacokinetics Services Market Analysis - by Drug Type

8. Pharmacokinetics Services Market Analysis - by Service Type

9. Pharmacokinetics Services Market Analysis - by Therapeutic Application

10. Pharmacokinetics Services Market Analysis - by End User

11. Pharmacokinetics Services Market - Geographical Analysis

12. Company Profile

13. Appendix

薬物動態サービスの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート：薬剤タイプ別、サービスタイプ別、治療用途別、エンドユーザー別、地域別

Pharmacokinetics Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Type, Service Type, Therapeutic Application, and End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 薬物動態サービス市場情勢

第5章 薬物動態サービス市場：主要市場力学

第6章 薬物動態サービス市場-世界市場分析

第7章 薬物動態サービス市場分析：薬物タイプ別

第8章 薬物動態サービス市場分析：サービスタイプ別

第9章 薬物動態サービス市場分析：治療用途別

第10章 薬物動態サービス市場分析：エンドユーザー別

第11章 薬物動態サービス市場：地域別分析

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Pharmacokinetics Services Market Landscape

5. Pharmacokinetics Services Market - Key Market Dynamics

6. Pharmacokinetics Services Market - Global Market Analysis

7. Pharmacokinetics Services Market Analysis - by Drug Type

8. Pharmacokinetics Services Market Analysis - by Service Type

9. Pharmacokinetics Services Market Analysis - by Therapeutic Application

10. Pharmacokinetics Services Market Analysis - by End User

11. Pharmacokinetics Services Market - Geographical Analysis

12. Company Profile

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章薬物動態サービス市場情勢

第5章薬物動態サービス市場：主要市場力学

第6章薬物動態サービス市場-世界市場分析

第7章薬物動態サービス市場分析：薬物タイプ別

第8章薬物動態サービス市場分析：サービスタイプ別

第9章薬物動態サービス市場分析：治療用途別

第10章薬物動態サービス市場分析：エンドユーザー別

第11章薬物動態サービス市場：地域別分析

第12章企業プロファイル

第13章付録